EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseOpen Access

Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke

Johannes Kaesmacher, Fabiano Cavalcante, Manon Kappelhof, Kilian M Treurniet, Leon Rinkel, Jianmin Liu, Bernard Yan, Wenjie Zi, Kazumi Kimura, Omer F Eker, Yongwei Zhang, Eike I Piechowiak und 23 weitere

JAMA · 05.03.2024 · 331 (9) · 764

DOI: 10.1001/jama.2024.0589 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JAMA, erschienen am 05.03.2024. Verfasst von Johannes Kaesmacher und 34 weiteren Autor:innen. Beteiligte Einrichtung: University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Brain Ischemia, Fibrinolytic Agents, Ischemic Stroke, Thrombectomy. Die Arbeit wurde bisher 134-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The benefit of intravenous thrombolysis (IVT) for acute ischemic stroke declines with longer time from symptom onset, but it is not known whether a similar time dependency exists for IVT followed by thrombectomy.

Objective

To determine whether the benefit associated with IVT plus thrombectomy vs thrombectomy alone decreases with treatment time from symptom onset. Design, Setting, and Participants Individual participant data meta-analysis from 6 randomized clinical trials comparing IVT plus thrombectomy vs thrombectomy alone. Enrollment was between January 2017 and July 2021 at 190 sites in 15 countries. All participants were eligible for IVT and thrombectomy and presented directly at thrombectomy-capable stroke centers (n = 2334). For this meta-analysis, only patients with an anterior circulation large-vessel occlusion were included (n = 2313). Exposure Interval from stroke symptom onset to expected administration of IVT and treatment with IVT plus thrombectomy vs thrombectomy alone. Main Outcomes and Measures The primary outcome analysis tested whether the association between the allocated treatment (IVT plus thrombectomy vs thrombectomy alone) and disability at 90 days (7-level modified Rankin Scale [mRS] score range, 0 [no symptoms] to 6 [death]; minimal clinically important difference for the rates of mRS scores of 0-2: 1.3%) varied with times from symptom onset to expected administration of IVT.

Results

In 2313 participants (1160 in IVT plus thrombectomy group vs 1153 in thrombectomy alone group; median age, 71 [IQR, 62 to 78] years; 44.3% were female), the median time from symptom onset to expected administration of IVT was 2 hours 28 minutes (IQR, 1 hour 46 minutes to 3 hours 17 minutes). There was a statistically significant interaction between the time from symptom onset to expected administration of IVT and the association of allocated treatment with functional outcomes (ratio of adjusted common odds ratio [OR] per 1-hour delay, 0.84 [95% CI, 0.72 to 0.97], P = .02 for interaction). The benefit of IVT plus thrombectomy decreased with longer times from symptom onset to expected administration of IVT (adjusted common OR for a 1-step mRS score shift toward improvement, 1.49 [95% CI, 1.13 to 1.96] at 1 hour, 1.25 [95% CI, 1.04 to 1.49] at 2 hours, and 1.04 [95% CI, 0.88 to 1.23] at 3 hours). For a mRS score of 0, 1, or 2, the predicted absolute risk difference was 9% (95% CI, 3% to 16%) at 1 hour, 5% (95% CI, 1% to 9%) at 2 hours, and 1% (95% CI, −3% to 5%) at 3 hours. After 2 hours 20 minutes, the benefit associated with IVT plus thrombectomy was not statistically significant and the point estimate crossed the null association at 3 hours 14 minutes. Conclusions and Relevance In patients presenting at thrombectomy-capable stroke centers, the benefit associated with IVT plus thrombectomy vs thrombectomy alone was time dependent and statistically significant only if the time from symptom onset to expected administration of IVT was short.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain IschemiaFibrinolytic AgentsIschemic StrokeThrombectomyThrombolytic TherapyAgedFemaleHumansMaleMiddle AgedAdministration, IntravenousRandomized Controlled Trials as TopicRecovery of FunctionStrokeTime-to-TreatmentTreatment Outcome

Substanzen

Fibrinolytic Agents

Autor:innen und Institutionen

  • University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, University of Bern, Bern, Switzerland.
  • Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Department of Radiology, Haaglanden Medical Center, the Hague, the Netherlands.
  • Department of Neurology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands.
  • Neurovascular Center, Naval Medical University Changhai Hospital, Shanghai, China.
  • Oriental Pan-Vascular Devices Innovations College, University of Shanghai for Science and Technology, Shanghai, China.

Zitieren

APA

Kaesmacher, J., Cavalcante, F., Kappelhof, M., Treurniet, K. M., Rinkel, L., Liu, J., Yan, B., Zi, W., Kimura, K., Eker, O. F., Zhang, Y., Piechowiak, E. I., van Zwam, W., Liu, S., Strbian, D., Uyttenboogaart, M., Dobrocky, T., Miao, Z., Suzuki, K., …, & IRIS Collaborators (2024). Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke. JAMA, 331(9), 764. https://doi.org/10.1001/jama.2024.0589

Vancouver

Kaesmacher J, Cavalcante F, Kappelhof M, Treurniet KM, Rinkel L, Liu J, et al. Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke. JAMA. 2024;331(9):764. doi:10.1001/jama.2024.0589

BibTeX
@article{Kaesmacher2024,
  author = {Kaesmacher, Johannes and Cavalcante, Fabiano and Kappelhof, Manon and Treurniet, Kilian M and Rinkel, Leon and Liu, Jianmin and Yan, Bernard and Zi, Wenjie and Kimura, Kazumi and Eker, Omer F and Zhang, Yongwei and Piechowiak, Eike I and van Zwam, Wim and Liu, Sheng and Strbian, Daniel and Uyttenboogaart, Maarten and Dobrocky, Tomas and Miao, Zhongrong and Suzuki, Kentaro and Zhang, Lei and van Oostenbrugge, Robert and Meinel, Thomas R and Guo, Changwei and Seiffge, David and Yin, Congguo and Bütikofer, Lukas and Lingsma, Hester and Nieboer, Daan and Yang, Pengfei and Mitchell, Peter and Majoie, Charles and Fischer, Urs and Roos, Yvo and Gralla, Jan and IRIS Collaborators, IRIS Collaborators},
  title = {Time to Treatment With Intravenous Thrombolysis Before Thrombectomy and Functional Outcomes in Acute Ischemic Stroke},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {9},
  pages = {764},
  doi = {10.1001/jama.2024.0589}
}
Kostenlos starten →